You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 269 No. 6, February 10, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Intensive care, survival, and expense of treating critically ill cancer patients

D. V. Schapira, J. Studnicki, D. D. Bradham, P. Wolff and A. Jarrett
Section of Cancer Prevention, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612.

OBJECTIVE--To determine the survival and factors affecting the survival of patients with solid tumors and hematologic cancers who were admitted to the intensive care unit, the time these patients spent at home (meaningful survival) before they died, and the cost per year of life gained and per year of life gained at home. DESIGN--Survival and cost-effectiveness analysis. SETTING--A tertiary-care cancer center at a university medical center. PATIENTS--Every patient admitted to the intensive care unit between July 1, 1988, and June 30, 1990, was entered into the study. This group comprised 83 patients with solid tumors and 64 patients with hematologic cancers. MAIN OUTCOME MEASURES--Factors affecting survival, such as age, sex, malignancy, length of stay in the intensive care unit, and necessity for mechanical ventilator assistance, as well as cost per year of life gained and cost per year of life gained at home. RESULTS--The only factor that significantly affected survival was the requirement for mechanically assisted ventilation for patients with hematologic cancers. More than three fourths of the patients in either group spent less than 3 months at home before dying. The cost per year of life gained for patients with solid tumors was $82,845 and for patients with hematologic cancers was $189,339. The cost per year of life gained at home was $95,142 for patients with solid tumors and $449,544 for patients with hematologic cancers. CONCLUSION--The majority of patients with solid tumors and hematologic cancers admitted to the intensive care unit die before discharge, or, if they survive the hospital admission, they spend a minimal amount of time at home before dying. This limited survival is achieved at considerable cost. Physicians who treat patients with neoplastic disease should discuss potential outcomes and the possibility of withdrawing life-supportive therapy if appropriate with the patient and family, so that a reasonable strategy can be agreed on before the initiation of therapy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit
Adam and Soubani
Eur Respir J 2008;31:47-53.
ABSTRACT | FULL TEXT  

Outcome and code status of lung cancer patients admitted to the medical ICU.
Reichner et al.
Chest 2006;130:719-723.
ABSTRACT | FULL TEXT  

Prognostic Accuracy of Acute Physiology and Chronic Health Evaluation II Scores in Critically Ill Cancer Patients
Chang et al.
Am J Crit Care 2006;15:47-53.
ABSTRACT | FULL TEXT  

Hospital Discharge to Care Facility: A Patient-Centered Outcome for the Evaluation of Intensive Care for Octogenarians
Rady and Johnson
Chest 2004;126:1583-1591.
ABSTRACT | FULL TEXT  

Outcome in Noninvasively and Invasively Ventilated Hematologic Patients With Acute Respiratory Failure
Depuydt et al.
Chest 2004;126:1299-1306.
ABSTRACT | FULL TEXT  

Hospital charges for a community inpatient palliative care program
Cowan
AM J HOSP PALLIAT CARE 2004;21:177-190.
ABSTRACT  

Outcomes of and Resource Consumption by High-Cost Patients in the Intensive Care Unit
Welton et al.
Am J Crit Care 2002;11:467-473.
ABSTRACT | FULL TEXT  

Can Health Care Costs Be Reduced by Limiting Intensive Care at the End of Life?
LUCE and RUBENFELD
Am. J. Respir. Crit. Care Med. 2002;165:750-754.
FULL TEXT  

Cost and Outcome of Mechanical Ventilation for Life-Threatening Stroke
Mayer et al.
Stroke 2000;31:2346-2353.
ABSTRACT | FULL TEXT  

Outcomes of Critically Ill Cancer Patients in a University Hospital Setting
KRESS et al.
Am. J. Respir. Crit. Care Med. 1999;160:1957-1961.
ABSTRACT | FULL TEXT  

Outcome for Cancer Patients Requiring Mechanical Ventilation
Groeger et al.
JCO 1999;17:991-991.
ABSTRACT | FULL TEXT  

Massage as a respite intervention for primary caregivers
MacDonald
AM J HOSP PALLIAT CARE 1998;15:43-47.
ABSTRACT  

Have Medicaid Reimbursements Been a Credible Measure of the Cost of Pediatric Care?
Broyles et al.
Pediatrics 1997;99:e8-e8.
ABSTRACT | FULL TEXT  

The Economics of Dying -- The Illusion of Cost Savings at the End of Life
Emanuel and Emanuel
NEJM 1994;330:540-544.
FULL TEXT  

THE HIGH COSTS OF TREATING TERMINAL CANCER
JWatch General 1993;1993:9-9.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.